Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results> Junesentai Pharmaceutical (02511.HK) Narrows Annual Loss to RMB245 Million
Recommend 0 Positive 0 Negative 0 |
||||
|
||||
|
Junesentai Pharmaceutical-B (02511.HK) announced its results for the fiscal year 2025, reporting other income of RMB19.01 million, a year-on-year decrease of 72%. The loss narrowed from RMB382 million in the previous year to RMB245 million, with a loss per share of RMB0.51. No final dividend was declared. (de/d) Auto-translated by third-party software This translation was auto-generated by third-party software. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
